Sanofi: xbrl:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod
| Value | {"unit": "EUR", "value": 15000000} |
|---|---|
| Period | 2025-01-01 – 2025-06-30 |
| Status | current |
| Entity | Sanofi |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:13:46.093769+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/2c8dba2e-ac3c-4511-af8b-f6ebb9a293d9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001121404-25-000022 · Open the official SEC filing →Retrieved: 2026-08-19T11:13:46.093769+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/2c8dba2e-ac3c-4511-af8b-f6ebb9a293d9
History
- no predecessors — first report